Chemotherapy & More
- This forum has 1,141 topics, 3,414 replies, and was last updated 5 hours, 31 minutes ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
-
Our New Discussion Board is HERE
1
2
3
Started by:
in: Announcements
- 17
- 31
- 8 months ago
- Derazantinib Showed Clinical Benefit as a Second-Line Treatment for Patients Wit
- 1
- 1
- 5 hours, 32 minutes ago
- Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS
- 1
- 1
- 4 days, 15 hours ago
- Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advan
- 1
- 1
- 5 days, 16 hours ago
- Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin trea
- 1
- 1
- 1 week, 3 days ago
- Pemigatinib in previously treated Chinese patients with locally advanced or meta
- 1
- 1
- 1 week, 3 days ago
- Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Deh
- 1
- 1
- 1 week, 6 days ago
- Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients
- 1
- 2
- 1 week, 6 days ago
- Successful control of a large intrahepatic cholangiocarcinoma treated by transar
- 1
- 1
- 2 weeks, 2 days ago
- Second-line chemotherapy for advanced biliary tract provides modest efficacy but
- 1
- 1
- 2 weeks, 6 days ago
-
Our New Discussion Board is HERE
1
2
3
- You must be logged in to create new topics.